Gem third batch of new shares tomorrow purchase Huayi Brothers or become the first choice

Just completed the second batch of gem new stock purchase, the third batch of gem IPO.　　Tomorrow, last week to purchase 3 SME board investors can continue to participate in the third batch of 9 gem new shares of the purchase. Compared with the second instalment, Wanguo-level market analyst Lin Jin in its research report that the 9 gem companies in the overall market share and competitiveness slightly lower.　　In view of this, while the issue of P/E is still high, it is recommended to make more fundamental choices and be more cautious about possible uncertainties about earnings forecasts. Lin Jin Analysis, the third batch of gem Company's average gross profit level is lower than the first two batches of gem new shares, for 36.7%, but there are also leaders, such as the Red Sun Medicine and Huayi Brothers, of which, the Red Sun medicine is significantly higher than the chemical agents industry and the average level of Chinese medicine industry.　　In the next three years, the expected growth in earnings, Huayi Brothers, the expected composite growth rate of EPS is the most bright eye. As the mainland's first domestic-listed film and television production company, Huayi Brothers became the star of the group. CICC pointed out that Huayi Brothers is the mainland film and television entertainment industry's leading enterprises, with a complete "Film + TV + Artists Brokerage" business model, has a greater synergy.　　Although the intrinsic volatility characteristics of the film business are obvious, the company still has a good prospect in view of the huge growth potential of the mainland film and entertainment industry and the core competitive advantages of the company in talent, brand and capital. Therefore, CICC believes that growth will continue to be the main line of investment value of Huayi Brothers. Comprehensive film and television entertainment industry status and corporate development planning, the company is expected to 2009-2011 years EPS for 0.50 yuan, 0.70 yuan and 0.92 yuan, respectively, year-on-year growth of 23%, 40% and 32%.　　To give the company 2010 reasonable P/e 35~40 times, reasonable price range of 24.5~28 yuan. According to wind information statistics, a number of brokers on the 9 new shares of reasonable valuations remain divided. Although CICC gives Huayi brothers a reasonable price of 28 yuan, Guotai thinks its reasonable valuation can reach 33 to 40 yuan. The same as the robot, Everbright Securities and Guotai that its reasonable valuation limit of not more than 40 yuan, but Shanghai Securities gives 58.78 to 64.65 yuan valuation.　　and three investment institutes to the Red Sun Pharmaceutical valuation difference is not big, think its reasonable share price between 55 to 65 yuan. This week issued two batches of gem new shares may be the start of the business board before the final purchase of new shares, and after the gem may not carry out such a large density distribution, will lead to a sharp drop in the rate. Therefore, the securities also suggested that investors should actively subscribe to the Gem IPO.　　For the third instalment, can be a priority to purchase robots, Red Sun Medicine, Huayi Brothers, Silver shares. Citic Securities also believes that after the meeting and the proposed company's profits and new shares will be less than the overall size of the first batch, and the gem after the listing of the wealth effect will also be expected to further stimulate the opening of the gem and the increase in the size of the growth of funds, so the expected future gem IPO will be a declineTrend。 And Lin Jin based on the third batch of 9 gem new stock profitability, performance growth, theme, highlights, circulating capital and other comprehensive judgments, Huayi Brothers, Red Sun Pharmaceutical industry's success rate is relatively high.　　If the emphasis on fundamentals, in addition to Huayi Brothers and the Red Sun pharmaceutical industry, but also attention to robots, and Jinya technology, Silver shares in the market is not high in the premise of the failure rate may also be "unexpectedly" higher. Appendix _ Gem of the third batch of new shares issued information source: This newspaper tidy up the stock name circulation (million shares) the investment price report the issue price to be completely diluted after the net profit issue the total equity industry net valuation interval (yuan) (yuan) (RMB) PE (times) (million)